Articles dans des revues avec comité de lecture (368)
154.
Najar, M., Rouas, R., Raicevic, G., Boufker, H. I., Lewalle, P., Meuleman, N., Bron, D., Toungouz Nevessignsky, M., Martiat, P., & Lagneaux, L. (2009). Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6. Cytotherapy, 11(5), 570-583. doi:10.1080/14653240903079377157.
Ravoet, C., Mineur, P., Robin, V., Debusscher, L., Bosly, A., André, M. J., El Housni, H., Soree, A., Bron, D., & Martiat, P. (2008). Farnesyl transferase inhibitor (lonafarnib) in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia: a phase II study. Annals of hematology, 87(11), 881-885. doi:10.1007/s00277-008-0536-2158.
Defoiche, J., Debacq, C., Asquith, B., Zhang, Y., Burny, A., Bron, D., Lagneaux, L., Macallan, D., & Willems, L. (2008). Reduction of B cell turnover in chronic lymphocytic leukaemia. British journal of haematology, 143(2), 240-247. doi:10.1111/j.1365-2141.2008.07348.x159.
Kemdem, A., Ahmad, I., Ysebrant De Lendonck, L., Nouar, E. H., Silance, P.-G., Aoun, M., Bron, D., & Vandenbossche, J. L. (2008). An Aspergillus myocardial abscess diagnosed by echocardiography. Journal of the American Society of Echocardiography, 21(10), 1177. doi:10.1016/j.echo.2007.10.010160.
Meuleman, N., Stamatopoulos, B., Dejeneffe, M., El Housni, H., Lagneaux, L., & Bron, D. (2008). Doubling time of soluble CD23: a powerful prognostic factor for newly diagnosed and untreated stage A chronic lymphocytic leukemia patients. Leukemia, 22(10), 1882-1890. doi:10.1038/leu.2008.190161.
Delrieu, V., Ngirabacu, M.-C., Ahmad, I., Azerad, M.-A., Meuleman, N., Dargent, J.-L., Cantinieaux, B., & Bron, D. (2008). Méningites lymphomateuses: Prophylaxie et traitement. Hématologie, 14(4), 300-305. doi:10.1684/hma.2008.0276162.
Bosly, A., Bron, D., van Hoof, A., De Bock, R., Berneman, Z. N., Ferrant, A., Kaufman, L., Dauwe, M., & Verhoef, G. (2008). Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP. Annals of hematology, 87(4), 277-283. doi:10.1007/s00277-007-0399-y163.
Bron, D., De Bruyn, C., Balasse, H., Ley, P., De Hemptinne, D., von Lennep, E., Homans, C., Marckowicz, E., Mathieu, P., Deleuse, M.-D., Francotte, J., Thomas, D. R., Dorval, C., Dejeneffe, M., Andrien, M., & Delforge, A. (2008). Le sang de cordon: du laboratoire au lit du malade. Bulletin du cancer, 95(3), 314-319. doi:10.1684/bdc.2008.0589164.
Adès, L., Sanz, M. A., Chevret, S., Montesinos, P., Chevallier, P., Raffoux, E., Vellenga, E., Guerci, A., Pigneux, A., Huguet, F., Rayon, C., Stoppa, A. M., de la Serna, J., Cahn, J.-Y., Meyer-Monard, S., Pabst, T., Thomas, X., de Botton, S., Parody, R., Bergua, J., Lamy, T., Vekhoff, A., Negri, S., Ifrah, N., Dombret, H., Ferrant, A., Bron, D., Degos, L., & Fenaux, P. (2008). Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results. Blood, 111(3), 1078-1084. doi:10.1182/blood-2007-07-099978165.
Tondreau, T., Dejeneffe, M., Meuleman, N., Stamatopoulos, B., Delforge, A., Martiat, P., Bron, D., & Lagneaux, L. (2008). Gene expression pattern of functional neuronal cells derived from human bone marrow mesenchymal stromal cells. BMC genomics, 9, 166. doi:10.1186/1471-2164-9-166